RAL
GILD icon

Range Advisory, LLC’s Gilead Sciences GILD Stock Holding History

Range Advisory, LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
2,668
+359
+16% +$47.3K 0.04% 223
2026
Q1 		$322K Buy
2,309
+466
+25% +$65.3K 0.06% 181
2025
Q4 		$226K Buy
+1,843
New +$224K 0.06% 175

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Range Advisory, LLC's GILD Position: Q2 2026 in Review

Range Advisory, LLC increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $47.3K and bringing the position to 2,668 shares worth $337K. The position accounts for 0.04% of the portfolio, ranked #223.

Range Advisory, LLC first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Range Advisory, LLC held 2,668 shares of Gilead Sciences worth $337K as of Q2 2026.
  • Range Advisory, LLC bought 359 Gilead Sciences shares in Q2 2026, an estimated $47.3K.
  • Gilead Sciences made up 0.04% of Range Advisory, LLC's portfolio in Q2 2026, its #223 holding.
  • Range Advisory, LLC first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.